Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant

被引：7
|
作者：
Li, Gen [1 ]
Zhou, Zhongcheng [1 ]
Du, Peng [1 ]
Zhan, Meixiao [2 ]
Li, Ning [1 ]
Xiong, Xinxin [1 ]
Tang, Shengjun [1 ]
Man, Miao [2 ,3 ,4 ,5 ,6 ]
Baptista-Hon, Daniel T. [2 ,3 ,4 ,5 ,6 ]
Lu, Ligong [2 ]
机构：
[1] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China
[2] Macau Univ Technol, Zhuhai Peoples Hosp, Affiliated Hosp 1, Zhuhai Precis Med Ctr,Fac Med, Zhuhai, Guangdong, Peoples R China
[3] Guangzhou Lab, Dept Bioinformat & AI, Guangzhou, Peoples R China
[4] Macau Univ Sci & Technol, Univ Hosp, Taipa 999078, Macao, Peoples R China
[5] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Taipa 999078, Macao, Peoples R China
[6] Macau Univ Sci & Technol, Fac Med, Taipa 999078, Macao, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2022年 / 7卷 / 01期
关键词：
D O I：
10.1038/s41392-022-01062-3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
    Ryuta Uraki
    Maki Kiso
    Shun Iida
    Masaki Imai
    Emi Takashita
    Makoto Kuroda
    Peter J. Halfmann
    Samantha Loeber
    Tadashi Maemura
    Seiya Yamayoshi
    Seiichiro Fujisaki
    Zhongde Wang
    Mutsumi Ito
    Michiko Ujie
    Kiyoko Iwatsuki-Horimoto
    Yuri Furusawa
    Ryan Wright
    Zhenlu Chong
    Seiya Ozono
    Atsuhiro Yasuhara
    Hiroshi Ueki
    Yuko Sakai-Tagawa
    Rong Li
    Yanan Liu
    Deanna Larson
    Michiko Koga
    Takeya Tsutsumi
    Eisuke Adachi
    Makoto Saito
    Shinya Yamamoto
    Masao Hagihara
    Keiko Mitamura
    Tetsuro Sato
    Masayuki Hojo
    Shin-ichiro Hattori
    Kenji Maeda
    Riccardo Valdez
    Moe Okuda
    Jurika Murakami
    Calvin Duong
    Sucheta Godbole
    Daniel C. Douek
    Ken Maeda
    Shinji Watanabe
    Aubree Gordon
    Norio Ohmagari
    Hiroshi Yotsuyanagi
    Michael S. Diamond
    Hideki Hasegawa
    Hiroaki Mitsuya
    Nature, 2022, 607 : 119 - 127
  • [22] Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
    Yamasoba, Daichi
    Kimura, Izumi
    Nasser, Hesham
    Morioka, Yuhei
    Nao, Naganor
    Ito, Jumpei
    Uriu, Keiya
    Tsuda, Masumi
    Zahradnik, Jiri
    Shirakawa, Kotaro
    Suzuki, Rigel
    Kishimoto, Mai
    Kosugi, Yusuke
    Kobiyama, Kouji
    Hara, Teppei
    Toyoda, Mako
    Tanaka, Yuri L.
    Butlertanaka, Erika P.
    Shimizu, Ryo
    Ito, Hayato
    Wang, Lei
    Oda, Yoshitaka
    Orba, Yasuko
    Sasaki, Michihito
    Nagata, Kayoko
    Yoshimatsu, Kumiko
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Kuramochi, Jin
    Seki, Motoaki
    Fujiki, Ryoji
    Kaneda, Atsushi
    Shimada, Tadanaga
    Nakada, Taka-aki
    Sakao, Seiichiro
    Suzuki, Takuji
    Ueno, Takamasa
    Takaori-Kondo, Akifumi
    Ishii, Ken J.
    Schreiber, Gideon
    Sawa, Hirofumi
    Saito, Akatsuki
    Irie, Takashi
    Tanaka, Shinya
    Matsuno, Keita
    Fukuhara, Takasuke
    Ikeda, Terumasa
    Sato, Kei
    CELL, 2022, 185 (12) : 2103 - +
  • [23] Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series
    Sherman, Amy C.
    van Haren, Simon D.
    Borberg, Ella
    Swank, Zoe
    Aleissa, Muneerah
    Tong, Alexandra
    Rooks, Rebecca
    Kanwal, Urwah
    Levine, Hannah
    Yates, Bridget
    Izaguirre, Natalie
    Ryff, Kevin
    Thomas, Sanya
    Parisi, Lindsey
    Li, Xiaofang
    Walt, David R.
    Levy, Ofer
    Walsh, Stephen R.
    Issa, Nicolas C.
    Baden, Lindsey R.
    VACCINE, 2024, 42 (22)
  • [24] Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
    Jing Zou
    Chaitanya Kurhade
    Hongjie Xia
    Mingru Liu
    Xuping Xie
    Ping Ren
    Pei-Yong Shi
    Nature Communications, 13
  • [25] Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
    Evans, John P.
    Zeng, Cong
    Qu, Panke
    Faraone, Julia
    Zheng, Yi-Min
    Carlin, Claire
    Bednash, Joseph S.
    Zhou, Tongqing
    Lozanski, Gerard
    Mallampalli, Rama
    Saif, Linda J.
    Oltz, Eugene M.
    Mohler, Peter J.
    Xu, Kai
    Gumina, Richard J.
    Liu, Shan-Lu
    CELL HOST & MICROBE, 2022, 30 (08) : 1093 - +
  • [26] Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
    Zou, Jing
    Kurhade, Chaitanya
    Xia, Hongjie
    Liu, Mingru
    Xie, Xuping
    Ren, Ping
    Shi, Pei-Yong
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [27] Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
    Pastorio, Chiara
    Zech, Fabian
    Noettger, Sabrina
    Jung, Christoph
    Jacob, Timo
    Sanderson, Theo
    Sparrer, Konstantin M. J.
    Kirchhoff, Frank
    CELL HOST & MICROBE, 2022, 30 (09) : 1255 - +
  • [28] Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
    Medits, Iris
    Springer, David N.
    Graninger, Marianne
    Camp, Jeremy V.
    Hoeltl, Eva
    Aberle, Stephan W.
    Traugott, Marianna T.
    Hoepler, Wolfgang
    Deutsch, Josef
    Lammel, Oliver
    Borsodi, Christian
    Puchhammer-Stoeckl, Elisabeth
    Zoufaly, Alexander
    Weseslindtner, Lukas
    Aberle, Judith H.
    Stiasny, Karin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
    Xiaoqi Yu
    Dong Wei
    Wenxin Xu
    Yulong Li
    Xinxin Li
    Xinxin Zhang
    Jieming Qu
    Zhitao Yang
    Erzhen Chen
    Cell Discovery, 8
  • [30] Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
    Wang, Xun
    Zhao, Xiaoyu
    Song, Jieyu
    Wu, Jing
    Zhu, Yuqi
    Li, Minghui
    Cui, Yuchen
    Chen, Yanjia
    Yang, Lulu
    Liu, Jun
    Zhu, Huanzhang
    Jiang, Shibo
    Wang, Pengfei
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 477 - 481
12345